NeutralLOW severityHealthcare & Pharma9d ago

Chemed executive vice president Lee sells $494,196 in stock

Chemed executive vice president Lee sells $494,196 in stock — $CHE one-month chart
$CHE daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOK’s read

Chemed shares closed near their 52-week high, trading at $528.05, just below the $562.24 peak. The stock is now in the upper part of its yearly range, with recent coverage concentrated in the last week but mostly neutral in tone. The Health Care sector shows calm today, though the story came over the weekend when the market was closed.

Written by Wook AI Nov 8, 6:29 AM ET from this page’s own figures at that time — not from the article — with every number checked against them. Not investment advice.

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about CHE. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · chemedEvent risk Low

Nothing reported about chemed across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.

From here · last month’s volatility 28% a year
Now $546.75Week $525.50–$568.00 (±3.9%)Month $503.20–$590.30 (±8.0%)
Ask Wook AI

Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.

Wook analysis

What it means

Key points
  • What to watch: The headline hangs on one number ($494,196) — one data point is a snapshot, so the trailing trend is the context it needs.
  • How the stock is trading: $CHE -0.49% in the latest session.
  • Timing: It was published over the weekend. The change shown is Friday's, and Monday is the first session that could react. Market holidays are not detected.
Amount$494,196

Where the stock stands

Chemed ($CHE) slipped 0.49% to $546.75 in the latest session. Over the past month it is up 7.6%. That leaves it 2.8% below its 52-week high of $562.24 and 50% above its low of $365.21, close to the top of its range. The high sits 54% above the low, a wide range for one year.

How much coverage it is getting

Wook has filed 4 stories on Chemed in the last 30 days, 1 of them this week. That is about its usual pace: over the month it has averaged about 1 a week. Going by their wording, 0 read bullish, 4 neutral and 0 bearish. This one reads neutral too, in line with most of them. Investing.com wrote 3 of the 4 (75%), so the count reflects one outlet's output more than broad attention.

The bigger picture

Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once.

What to watch next

For the company's side of it, read its latest SEC filings on the $CHE page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Most of the recent coverage comes from one outlet, so check whether another newsroom has confirmed the story or is only repeating it. To run the numbers yourself, ask Wook AI above about $CHE: its distance from the high, its last report, or how coverage has changed.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Investing.com published this on November 8, 2026. $CHE has moved +2.93% ($531.21 to $546.75). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Investing.com. Wook of Wall Street is an independent research tool and is not affiliated with Investing.com. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy